Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,396
  • Shares Outstanding, K 41,658
  • Annual Sales, $ 118,900 K
  • Annual Income, $ -290 K
  • 60-Month Beta 1.73
  • Price/Sales 0.85
  • Price/Cash Flow 6.35
  • Price/Book 1.41
Trade HBIO with:

Options Overview Details

View History
  • Implied Volatility 111.87% ( +111.87%)
  • Historical Volatility 72.14%
  • IV Percentile 89%
  • IV Rank 15.98%
  • IV High 695.66% on 09/28/22
  • IV Low 0.82% on 10/06/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 397

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.06
  • Growth Rate Est. (year over year) -133.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.10 +14.76%
on 11/09/22
2.77 -13.00%
on 11/02/22
+0.11 (+4.78%)
since 10/25/22
3-Month
2.10 +14.76%
on 11/09/22
3.48 -30.75%
on 08/26/22
-0.99 (-29.12%)
since 08/25/22
52-Week
2.10 +14.76%
on 11/09/22
7.36 -67.26%
on 12/28/21
-4.71 (-66.15%)
since 11/24/21

Most Recent Stories

More News
Harvard Bioscience (HBIO) Reports Q3 Loss, Misses Revenue Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -120% and 3.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HBIO : 2.41 (-1.23%)
ZS : 138.75 (-0.95%)
Harvard Bioscience: Q3 Earnings Snapshot

Harvard Bioscience: Q3 Earnings Snapshot

HBIO : 2.41 (-1.23%)
Harvard Bioscience Announces Second Quarter 2022 Financial Results

HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the...

HBIO : 2.41 (-1.23%)
Bruker (BRKR) Meets Q2 Earnings Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 0% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

BRKR : 68.79 (+0.51%)
HBIO : 2.41 (-1.23%)
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET

HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended...

HBIO : 2.41 (-1.23%)
Are Options Traders Betting on a Big Move in Harvard Bioscience (HBIO) Stock?

Investors need to pay close attention to Harvard Bioscience (HBIO) stock based on the movements in the options market lately.

HBIO : 2.41 (-1.23%)
Harvard Bioscience (HBIO) Loses 35.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Harvard Bioscience (HBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates...

HBIO : 2.41 (-1.23%)
Harvard Bioscience (HBIO) Q1 Earnings and Revenues Lag Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

HBIO : 2.41 (-1.23%)
SCND : 5.5400 (+0.73%)
Harvard Bioscience Announces First Quarter 2022 Financial Results

 •Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwinds HOLLISTON, Mass., May 04, 2022 (GLOBE...

HBIO : 2.41 (-1.23%)
PerkinElmer (PKI) Beats Q1 Earnings and Revenue Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 15.87% and 6.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PKI : 136.93 (-0.32%)
HBIO : 2.41 (-1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

See More

Key Turning Points

3rd Resistance Point 2.65
2nd Resistance Point 2.55
1st Resistance Point 2.48
Last Price 2.41
1st Support Level 2.30
2nd Support Level 2.20
3rd Support Level 2.13

See More

52-Week High 7.36
Fibonacci 61.8% 5.35
Fibonacci 50% 4.73
Fibonacci 38.2% 4.11
Last Price 2.41
52-Week Low 2.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar